Germline heterozygous loss-of-function mutations in the SMARCA4 gene can result in rhabdoid tumor predisposition syndrome-2, which is associated with an increased risk of developing atypical teratoid/rhabdoid tumors and SCCOHT [73]. Here, SMARCA4 is linked to rhabdoid tumor.